These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22392777)

  • 1. [Postradiotherapy complications and their correction ways at patients with nasopharyngeal carcinoma].
    Aliev DA; Isaev IG; Kazieva RR
    Georgian Med News; 2012 Jan; (202):17-21. PubMed ID: 22392777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
    Lee AWM; Tung SY; Ng WT; Lee V; Ngan RKC; Choi HCW; Chan LLK; Siu LL; Ng AWY; Leung TW; Yiu HHY; O'Sullivan B; Chappell R
    Cancer; 2017 Nov; 123(21):4147-4157. PubMed ID: 28662313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
    Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
    Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma.
    Li HM; Li P; Qian YJ; Wu X; Xie L; Wang F; Zhang H; Liu L
    BMC Cancer; 2016 Dec; 16(1):946. PubMed ID: 27955638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma.
    Maoleekoonpairoj S; Phromratanapongse P; Puttanuparp S
    J Med Assoc Thai; 1997 Dec; 80(12):778-84. PubMed ID: 9470331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma].
    Xie FY; Qi SN; Hu WH; Zou GR; Peng M; Li JS
    Ai Zheng; 2007 Aug; 26(8):880-4. PubMed ID: 17697552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two cases of radiation-induced sarcoma after radiation therapy in nasopharyngeal carcinoma].
    Okoshi A; Shiga K; Sasaki K; Asada Y; Nishikawa H; Kobayashi T; Watanabe M
    Nihon Jibiinkoka Gakkai Kaiho; 2008 Jul; 111(7):533-6. PubMed ID: 18697477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiotherapy with concurrent chemotherapy for treatment of advanced nasopharyngeal carcinoma].
    Feng ZF; Pan HL; Song HS; Liu ZM; Huang Y
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):694-6. PubMed ID: 15201093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cis-diamminedichloroplatinum (CDDP)-radiation therapy in nasopharyngeal carcinoma].
    Chatani M; Teshima T; Inoue T; Tsuruta Y; Umatani K; Yoshino K; Miyahara H; Sato T
    Gan To Kagaku Ryoho; 1986 May; 13(5):1851-6. PubMed ID: 3707147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of radiotherapy combined with adjuvant chemotherapy in the treatment of patients with advanced nasopharyngeal carcinoma: a prospective study.
    Kong F; Cai B; Lin S; Zhang J; Wang Y; Fu Q
    J BUON; 2015; 20(1):206-11. PubMed ID: 25778317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A triplet chemotherapy regimen of cisplatin, fluorouracil and paclitaxel for locoregionally recurrent nasopharyngeal carcinoma cases contraindicated for re-irradiation/surgery.
    Wang Y; Wang ZQ; Jiang YX; Wang FH; Luo HY; Liang Y; Wang DS; Li YH
    Expert Opin Pharmacother; 2016 Aug; 17(12):1585-90. PubMed ID: 27328125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy was associated with a higher severe late toxicity rate in nasopharyngeal carcinoma patients compared with radiotherapy alone: a meta-analysis based on randomized controlled trials.
    Du CR; Ying HM; Kong FF; Zhai RP; Hu CS
    Radiat Oncol; 2015 Mar; 10():70. PubMed ID: 25889937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy with UFT and low dose weekly cisplatin for nasopharyngeal carcinoma.
    Park JH; Nam SY; Lee SW; Kim SB; Kim SY; Lee BJ; Cho KJ; Kim JH; Ahn SD; Shin SS; Choi SH; Ahn JH; Choi EK
    Auris Nasus Larynx; 2005 Mar; 32(1):43-8. PubMed ID: 15882825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China.
    Chen Y; Sun Y; Liang SB; Zong JF; Li WF; Chen M; Chen L; Mao YP; Tang LL; Guo Y; Lin AH; Liu MZ; Ma J
    Cancer; 2013 Jun; 119(12):2230-8. PubMed ID: 23576020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term efficacy of induction chemotherapy plus concurrent radiochemotherapy on advanced nasopharyngeal carcinoma].
    Liang Y; Gao JM; Hu WH; Gao YH; Xie FY
    Ai Zheng; 2007 Aug; 26(8):885-9. PubMed ID: 17697553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical assessment of the radiotherapy and chemotherapy combined with cetuximabin in the treatment of nasopharyngeal carcinoma].
    Wang XX
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Aug; 30(15):1229-1231. PubMed ID: 29798336
    [No Abstract]   [Full Text] [Related]  

  • 20. Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma.
    Teo PM; Kwan WH; Leung SF; Leung WT; Chan A; Choi P; Yu P; Lee WY; Johnson P
    Br J Radiol; 1996 Mar; 69(819):241-8. PubMed ID: 8800868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.